AlphaFold predicted structure
KDM5B · Q9UGL1

Mean pLDDT
72.3/ 100
Confident
1,544 residues
Confidence breakdown
- Very high(≥ 90)24%
- Confident(70–90)44%
- Low(50–70)9%
- Very low(< 50)23%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
lysine demethylase 5B
Annotations refreshed 7 hours ago.
Diagnostic Grade (Green)
DDG2P
BOTH monoallelic and biallelic, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalintellectual disability, autosomal recessive 65
neurodevelopmental disorder
hereditary disease
neurodegenerative disease
autosomal recessive non-syndromic intellectual disability
intellectual disability, autosomal recessive
autism spectrum disorder
Neurodevelopmental abnormality
Intellectual disability
psoriasis
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Lysine-specific demethylase 5B
Histone demethylase that demethylates 'Lys-4' of histone H3, thereby playing a central role in histone code (PubMed:24952722, PubMed:27214403, PubMed:28262558). Does not demethylate histone H3 'Lys-9' or H3 'Lys-27'. Demethylates trimethylated, dimethylated and monomethylated H3 'Lys-4'. Acts as a transcriptional corepressor for FOXG1B and PAX9. Favors the proliferation of breast cancer cells by repressing tumor suppressor genes such as BRCA1 and HOXA5 (PubMed:24952722). In contrast, may act as a tumor suppressor for melanoma. Represses the CLOCK-BMAL1 heterodimer-mediated transcriptional activation of the core clock component PER2 (By similarity)
Curated MONDO disease pages that list KDM5B among their top associated genes.
KDM5B · Q9UGL1

Mean pLDDT
72.3/ 100
Confident
1,544 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0